Hydralazine-induced vasculitis presenting with ocular manifestations

Am J Ophthalmol Case Rep. 2022 Apr 10:26:101515. doi: 10.1016/j.ajoc.2022.101515. eCollection 2022 Jun.

Abstract

Purpose: The objective of the study is to report a case of ocular manifestations in a patient with hydralazine-induced vasculitis.

Observations: An 88-year-old female was admitted for lower gastrointestinal bleeding. Nine days after admission, she developed bilateral conjunctival chemosis and injection, which rapidly progressed into grouped blistering eruptions of the periorbital skin, face, and neck. After extensive testing and evaluation, her constellation of findings was diagnosed as hydralazine-induced vasculitis. Treatment with intravenous steroids and discontinuation of hydralazine resulted in improvement of the cutaneous and ocular manifestations. Herein we describe the clinical course of an adult patient with symptoms and signs consistent with hydralazine-induced vasculitis to highlight that ophthalmological manifestations can be the first symptoms in patients with life-threatening dermatological conditions.

Conclusions and importance: To our knowledge, this report is the first case of hydralazine-induced vasculitis initially presenting with ocular manifestations.

Keywords: ANA, Anti-nuclear antibodies; Conjunctival chemosis; Conjunctival injection; DIV, Drug-induced vasculitis; HSV, Herpes simplex virus; Hydralazine; Vasculitis; c-ANCA, cytoplasmic antineutrophil cytoplasmic antibody; p-ANCA, perinuclear antineutrophil cytoplasmic antibody.

Publication types

  • Case Reports